Samsung SDS, a subsidiary of the Samsung group, plans to kick off beta testing of its new next-generation sequencing cloud-based data analysis service on Sept. 1, BioInform learned this week.
The beta is expected to last until November. As part of the test, the firm is offering to analyze one genome per researcher for free.
The company offers NGS analysis services including mapping, gene expression, alternative splicing, and fusion transcripts, among other applications for whole genome sequencing with a turnaround time of seven days; and for RNA-seq, with a turnaround time of three days.
The service accepts data from Life Technologies SOLiD 3 Plus, and SoLiD 4; Illumina's Genome Analyzer; and the HiSeq 1000 and 2000 platforms.